Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study.

Massimo Origoni, Chiara Stefani, Giacomo Dell'Antonio, Guia Carminati, Marta Parma, Massimo Candiani

Research output: Contribution to journalArticle

Abstract

Human Papillomavirus (HPV) is the leading cause of cervical cancer among women. Immunosuppression is recognized as one of the major risk factors for HPV infection and persistence. Aim of this study was to determine if solid organs (24 kidney and 24 kidney/pancreas) transplanted Italian women undergoing immunosuppressive therapies were at higher risk of HPV genital infection and cervical precancerous lesions in a ten-year follow-up. Forty-eight women that underwent transplant from 1990 to 2000, receiving multi-drug immunosuppressive therapy, were enrolled prospectively in a long-term follow-up protocol. Patients were cytologically (Pap smear) and virologically (HPV-DNA test) tested each year for 10 years. Incidence of HPV-DNA positivity and of cervical cytological/histological abnormalities was collected. Results were statistically analyzed and compared to a matching control group of 200 healthy women. HPV-DNA positivity and cytological High-Grade (HG-SIL) cervical lesions did not show statistically significant differences in cases compared to controls, while statistical significance was observed in Low-Grade (LG-SIL) cytological diagnoses. No statistically significant difference was observed in histology-proven cervical lesions. Women receiving immunosuppression therapy following transplant do not seem to require intensive follow-up, and should not be considered a high-risk subgroup, as they do not show a statistically significant higher incidence of HPV infections or high-grade cervical dysplasia compared to healthy immunocompetent matching controls.

Original languageEnglish
Pages (from-to)250-254
Number of pages5
JournalJournal of Clinical Virology
Volume51
Issue number4
Publication statusPublished - Aug 2011

Fingerprint

Papillomavirus Infections
Immunosuppressive Agents
Immunosuppression
Human Papillomavirus DNA Tests
Uterine Cervical Dysplasia
Transplants
Kidney
Papanicolaou Test
DNA
Incidence
Uterine Cervical Neoplasms
Pancreas
Histology
Drug Therapy
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cervical Human Papillomavirus in transplanted Italian women : a long-term prospective follow-up study. / Origoni, Massimo; Stefani, Chiara; Dell'Antonio, Giacomo; Carminati, Guia; Parma, Marta; Candiani, Massimo.

In: Journal of Clinical Virology, Vol. 51, No. 4, 08.2011, p. 250-254.

Research output: Contribution to journalArticle

Origoni, M, Stefani, C, Dell'Antonio, G, Carminati, G, Parma, M & Candiani, M 2011, 'Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study.', Journal of Clinical Virology, vol. 51, no. 4, pp. 250-254.
Origoni, Massimo ; Stefani, Chiara ; Dell'Antonio, Giacomo ; Carminati, Guia ; Parma, Marta ; Candiani, Massimo. / Cervical Human Papillomavirus in transplanted Italian women : a long-term prospective follow-up study. In: Journal of Clinical Virology. 2011 ; Vol. 51, No. 4. pp. 250-254.
@article{e81decd4acc84b93990c6f5994c6ad26,
title = "Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study.",
abstract = "Human Papillomavirus (HPV) is the leading cause of cervical cancer among women. Immunosuppression is recognized as one of the major risk factors for HPV infection and persistence. Aim of this study was to determine if solid organs (24 kidney and 24 kidney/pancreas) transplanted Italian women undergoing immunosuppressive therapies were at higher risk of HPV genital infection and cervical precancerous lesions in a ten-year follow-up. Forty-eight women that underwent transplant from 1990 to 2000, receiving multi-drug immunosuppressive therapy, were enrolled prospectively in a long-term follow-up protocol. Patients were cytologically (Pap smear) and virologically (HPV-DNA test) tested each year for 10 years. Incidence of HPV-DNA positivity and of cervical cytological/histological abnormalities was collected. Results were statistically analyzed and compared to a matching control group of 200 healthy women. HPV-DNA positivity and cytological High-Grade (HG-SIL) cervical lesions did not show statistically significant differences in cases compared to controls, while statistical significance was observed in Low-Grade (LG-SIL) cytological diagnoses. No statistically significant difference was observed in histology-proven cervical lesions. Women receiving immunosuppression therapy following transplant do not seem to require intensive follow-up, and should not be considered a high-risk subgroup, as they do not show a statistically significant higher incidence of HPV infections or high-grade cervical dysplasia compared to healthy immunocompetent matching controls.",
author = "Massimo Origoni and Chiara Stefani and Giacomo Dell'Antonio and Guia Carminati and Marta Parma and Massimo Candiani",
year = "2011",
month = "8",
language = "English",
volume = "51",
pages = "250--254",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Cervical Human Papillomavirus in transplanted Italian women

T2 - a long-term prospective follow-up study.

AU - Origoni, Massimo

AU - Stefani, Chiara

AU - Dell'Antonio, Giacomo

AU - Carminati, Guia

AU - Parma, Marta

AU - Candiani, Massimo

PY - 2011/8

Y1 - 2011/8

N2 - Human Papillomavirus (HPV) is the leading cause of cervical cancer among women. Immunosuppression is recognized as one of the major risk factors for HPV infection and persistence. Aim of this study was to determine if solid organs (24 kidney and 24 kidney/pancreas) transplanted Italian women undergoing immunosuppressive therapies were at higher risk of HPV genital infection and cervical precancerous lesions in a ten-year follow-up. Forty-eight women that underwent transplant from 1990 to 2000, receiving multi-drug immunosuppressive therapy, were enrolled prospectively in a long-term follow-up protocol. Patients were cytologically (Pap smear) and virologically (HPV-DNA test) tested each year for 10 years. Incidence of HPV-DNA positivity and of cervical cytological/histological abnormalities was collected. Results were statistically analyzed and compared to a matching control group of 200 healthy women. HPV-DNA positivity and cytological High-Grade (HG-SIL) cervical lesions did not show statistically significant differences in cases compared to controls, while statistical significance was observed in Low-Grade (LG-SIL) cytological diagnoses. No statistically significant difference was observed in histology-proven cervical lesions. Women receiving immunosuppression therapy following transplant do not seem to require intensive follow-up, and should not be considered a high-risk subgroup, as they do not show a statistically significant higher incidence of HPV infections or high-grade cervical dysplasia compared to healthy immunocompetent matching controls.

AB - Human Papillomavirus (HPV) is the leading cause of cervical cancer among women. Immunosuppression is recognized as one of the major risk factors for HPV infection and persistence. Aim of this study was to determine if solid organs (24 kidney and 24 kidney/pancreas) transplanted Italian women undergoing immunosuppressive therapies were at higher risk of HPV genital infection and cervical precancerous lesions in a ten-year follow-up. Forty-eight women that underwent transplant from 1990 to 2000, receiving multi-drug immunosuppressive therapy, were enrolled prospectively in a long-term follow-up protocol. Patients were cytologically (Pap smear) and virologically (HPV-DNA test) tested each year for 10 years. Incidence of HPV-DNA positivity and of cervical cytological/histological abnormalities was collected. Results were statistically analyzed and compared to a matching control group of 200 healthy women. HPV-DNA positivity and cytological High-Grade (HG-SIL) cervical lesions did not show statistically significant differences in cases compared to controls, while statistical significance was observed in Low-Grade (LG-SIL) cytological diagnoses. No statistically significant difference was observed in histology-proven cervical lesions. Women receiving immunosuppression therapy following transplant do not seem to require intensive follow-up, and should not be considered a high-risk subgroup, as they do not show a statistically significant higher incidence of HPV infections or high-grade cervical dysplasia compared to healthy immunocompetent matching controls.

UR - http://www.scopus.com/inward/record.url?scp=80055095523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055095523&partnerID=8YFLogxK

M3 - Article

C2 - 21680237

VL - 51

SP - 250

EP - 254

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

IS - 4

ER -